289 related articles for article (PubMed ID: 21355552)
1. Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
Chang KL; New LS; Mal M; Goh CW; Aw CC; Browne ER; Chan EC
J Proteome Res; 2011 Apr; 10(4):2079-87. PubMed ID: 21355552
[TBL] [Abstract][Full Text] [Related]
2. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
Pandey M; Varghese M; Sindhu KM; Sreetama S; Navneet AK; Mohanakumar KP; Usha R
J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
[TBL] [Abstract][Full Text] [Related]
7. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.
Cirillo G; Maggio N; Bianco MR; Vollono C; Sellitti S; Papa M
Neurochem Int; 2010 Jan; 56(1):152-60. PubMed ID: 19799953
[TBL] [Abstract][Full Text] [Related]
8. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.
Kumar P; Kalonia H; Kumar A
J Psychopharmacol; 2011 Oct; 25(10):1399-411. PubMed ID: 20305041
[TBL] [Abstract][Full Text] [Related]
9. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.
Sandhir R; Sood A; Mehrotra A; Kamboj SS
Neurodegener Dis; 2012; 9(3):145-57. PubMed ID: 22327485
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective mechanisms of brain-derived neurotrophic factor against 3-nitropropionic acid toxicity: therapeutic implications for Huntington's disease.
Wu CL; Hwang CS; Chen SD; Yin JH; Yang DI
Ann N Y Acad Sci; 2010 Jul; 1201():8-12. PubMed ID: 20649532
[TBL] [Abstract][Full Text] [Related]
12. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
Kumar P; Kumar A
Indian J Exp Biol; 2009 Sep; 47(9):715-22. PubMed ID: 19957883
[TBL] [Abstract][Full Text] [Related]
13. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A; Akula KK; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
Rossignol J; Boyer C; Lévèque X; Fink KD; Thinard R; Blanchard F; Dunbar GL; Lescaudron L
Behav Brain Res; 2011 Mar; 217(2):369-78. PubMed ID: 21070819
[TBL] [Abstract][Full Text] [Related]
17. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
[TBL] [Abstract][Full Text] [Related]
18. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
Mehrotra A; Sood A; Sandhir R
Mol Cell Biochem; 2015 Dec; 410(1-2):281-92. PubMed ID: 26374445
[TBL] [Abstract][Full Text] [Related]
20. Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats.
Kumar P; Kalonia H; Kumar A
J Asian Nat Prod Res; 2009; 11(5):439-50. PubMed ID: 19504387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
